• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血栓形成倾向、危险因素和预防。

Thrombophilia, risk factors and prevention.

机构信息

a Haemorrhagic and Thrombotic Diseases Unit, Department of Medicine (DIMED) , Padova University Hospital , Padova , Italy.

出版信息

Expert Rev Hematol. 2019 Mar;12(3):147-158. doi: 10.1080/17474086.2019.1583555. Epub 2019 Feb 26.

DOI:10.1080/17474086.2019.1583555
PMID:30773075
Abstract

Fifty-three years after the first description of an inherited prothrombotic condition (antithrombin deficiency), our knowledge on hereditary and acquired causes of hypercoagulability that can predispose carriers to venous thromboembolism (VTE) has greatly improved. Areas covered: Main causes of hereditary thrombophilia are summarized alongside new prothrombotic mutations recently discovered. The main causes of acquired thrombophilia, and namely, antiphospholipid antibody syndrome and hyperhomocysteinemia, are also discussed together with other common acquired prothrombotic states characterized by an increase of procoagulant factors and/or a decrease of natural anticoagulants. Finally, suggestions for thromboprophylaxis in carriers of hereditary thrombophilia according to current guidelines/evidence are made for the most challenging high-risk situations (i.e. surgery, pregnancy, contraception, cancer, economy class syndrome) as well as for the prevention of post-thrombotic syndrome. Expert opinion: A carrier of inherited thrombophilia should be evaluated in the framework of other (genetic and/or acquired) coexisting risk factors for first or recurrent VTE when assessing the need and duration of prevention (primary prophylaxis). Prevention strategies should be tailored to each patient and every situational risk factor. The knowledge of the carriership status of severe thrombophilia in the proband can be important to provide asymptomatic relatives with adequate counseling on thrombophilia screening or primary thromboprophylaxis.

摘要

在首次描述遗传性促血栓形成状态(抗凝血酶缺乏症)后的 53 年里,我们对遗传性和获得性高凝状态的病因的认识有了很大的提高,这些病因可使携带者易患静脉血栓栓塞症(VTE)。

涵盖的领域

总结了遗传性血栓形成倾向的主要原因,并介绍了最近发现的新的促血栓形成突变。还讨论了获得性血栓形成倾向的主要原因,即抗磷脂抗体综合征和高同型半胱氨酸血症,以及其他常见的获得性促血栓形成状态,其特征是促凝因子增加和/或天然抗凝剂减少。最后,根据当前指南/证据,针对遗传性血栓形成倾向携带者在最具挑战性的高风险情况下(即手术、妊娠、避孕、癌症、经济舱综合征)以及预防血栓后综合征,提出了血栓预防建议。

专家意见

在评估首次或复发性 VTE 的其他(遗传和/或获得性)共存危险因素时,应在遗传性血栓形成倾向携带者的背景下评估其需要和预防持续时间(一级预防)。预防策略应根据每个患者和每个情境危险因素进行调整。了解先证者严重血栓形成倾向的携带状态对于向无症状亲属提供有关血栓形成筛查或一级血栓预防的适当咨询非常重要。

相似文献

1
Thrombophilia, risk factors and prevention.血栓形成倾向、危险因素和预防。
Expert Rev Hematol. 2019 Mar;12(3):147-158. doi: 10.1080/17474086.2019.1583555. Epub 2019 Feb 26.
2
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review.遗传性易栓症携带者静脉血栓栓塞症一级和二级预防的知识进展:一项叙述性综述
Semin Thromb Hemost. 2022 Nov;48(8):937-948. doi: 10.1055/s-0042-1753527. Epub 2022 Sep 2.
3
Acquired Thrombophilia.获得性血栓形成倾向
J Pharm Pract. 2014 Jun;27(3):234-42. doi: 10.1177/0897190014530424. Epub 2014 Apr 17.
4
An Overview of Thrombophilia and Associated Laboratory Testing.血栓形成倾向及相关实验室检测概述
Methods Mol Biol. 2017;1646:113-135. doi: 10.1007/978-1-4939-7196-1_9.
5
The real value of thrombophilia markers in identifying patients at high risk of venous thromboembolism.血栓形成倾向标志物在识别静脉血栓栓塞高危患者中的实际价值。
Expert Rev Hematol. 2014 Dec;7(6):757-65. doi: 10.1586/17474086.2014.960385. Epub 2014 Sep 18.
6
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.高风险情况下的易栓症筛查:系统评价与成本效益分析。易栓症筛查的血栓形成:风险与经济评估(TREATS)研究。
Health Technol Assess. 2006 Apr;10(11):1-110. doi: 10.3310/hta10110.
7
Should patients with venous thromboembolism be screened for thrombophilia?静脉血栓栓塞症患者是否应该接受易栓症筛查?
Am J Med. 2008 Jun;121(6):458-63. doi: 10.1016/j.amjmed.2007.10.042.
8
Thrombophilia and cancer.血栓形成倾向与癌症
Pathophysiol Haemost Thromb. 2008;36(3-4):131-6. doi: 10.1159/000175151. Epub 2009 Jan 27.
9
Therapeutic Implications of Inherited Thrombophilia in Pregnancy.遗传性易栓症在妊娠期的治疗意义。
Am J Ther. 2019 May/Jun;26(3):e364-e374. doi: 10.1097/MJT.0000000000000985.
10
Modulating thrombotic diathesis in hereditary thrombophilia and antiphospholipid antibody syndrome: a role for circulating microparticles?调节遗传性易栓症和抗磷脂抗体综合征中的血栓形成倾向:循环微粒的作用?
Clin Chem Lab Med. 2017 Jun 27;55(7):934-943. doi: 10.1515/cclm-2016-0562.

引用本文的文献

1
Editorial: Case reports in thrombosis: 2024.社论:2024年血栓形成病例报告
Front Cardiovasc Med. 2025 May 1;12:1614440. doi: 10.3389/fcvm.2025.1614440. eCollection 2025.
2
"Unraveling the Clot-Miscarriage Nexus: Mechanisms, Management, and Future Directions in Thrombosis-Related Recurrent Pregnancy Loss".解析血栓与流产的关联:血栓相关复发性流产的机制、管理及未来方向
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251339421. doi: 10.1177/10760296251339421. Epub 2025 Apr 29.
3
Retinal Artery Occlusion: A Review of Current Management Practices.
视网膜动脉阻塞:当前治疗方法综述
J Ophthalmic Vis Res. 2024 Dec 31;19(4):488-507. doi: 10.18502/jovr.v19i4.16559. eCollection 2024 Dec.
4
Role of Prothrombin and Methylenetetrahydrofolate Reductase Gene Polymorphisms as well as Thrombophilia Markers, as Risk Factors for Unexplained Recurrent Miscarriage: A Case-Control Study.凝血酶原和亚甲基四氢叶酸还原酶基因多态性以及易栓症标志物作为不明原因复发性流产危险因素的作用:一项病例对照研究。
Int J Fertil Steril. 2025 Jan 5;19(1):36-43. doi: 10.22074/ijfs.2023.1986225.1418.
5
Evaluation of AT in acute pulmonary embolism with pleural effusion.急性肺栓塞伴胸腔积液时阿替普酶的评估。
Biomark Med. 2024;18(23):1017-1026. doi: 10.1080/17520363.2024.2395241. Epub 2024 Nov 27.
6
Ninety-Day Outcomes in Primary Hypercoagulable Disease Patients Undergoing Total Joint Arthroplasty Vs Normal: A Matched Case-Control Series.原发性高凝疾病患者与正常患者接受全关节置换术的90天结局:一项匹配病例对照研究系列
Arthroplast Today. 2024 Sep 18;29:101424. doi: 10.1016/j.artd.2024.101424. eCollection 2024 Oct.
7
Thrombosis and Thrombotic Risk in Athletes.运动员的血栓形成与血栓形成风险
J Clin Med. 2024 Aug 19;13(16):4881. doi: 10.3390/jcm13164881.
8
Morvan's syndrome with hypercoagulable condition in a patient positive for anti-CASPR2 antibodies: A case report.伴有抗 CASPR2 抗体阳性的高凝状态的莫尔万综合征:一例报告。
Medicine (Baltimore). 2024 Jul 19;103(29):e38929. doi: 10.1097/MD.0000000000038929.
9
Editorial: Case reports in thrombosis: 2023.社论:2023年血栓形成病例报告
Front Cardiovasc Med. 2024 Jul 1;11:1446992. doi: 10.3389/fcvm.2024.1446992. eCollection 2024.
10
Ramadan intermittent fasting is associated with improved anticoagulant activity among healthy people: a case-control study.斋月间歇性禁食与健康人群抗凝活性的改善相关:一项病例对照研究。
Sci Rep. 2024 Jun 15;14(1):13855. doi: 10.1038/s41598-024-64582-8.